Skip to main content
Caplight Logo









iHeart Japan Corporation

iHeart Japan Corporation

Private
KyotoHealthcare & Life Scienceshttps://iheartjapan.jp/

Last Round

Series D

Sep 1, 2025

Total Funding Raised

$29.73M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

iHeart Japan Corporation is a biotechnology company that develops allogeneic regenerative medical products derived from iPS cells for the treatment of heart failure.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

regenerative medicineinduced pluripotent stem cellsiPS cellsheart failure treatmentcardiovascular cell sheetbiotechdrug discoverytoxicity testingcell therapycontract researchregenerative therapybiomaterialscardiology researchstem cell researchlab-grown tissue

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iHeart Japan Corporation Comparables

Compare iHeart Japan Corporation with similar companies based on industry and business-model similarity.

iHeart Japan Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cuorips Inc.
87%
Heartseed
85%
Avery Therapeutics, Inc.
77%

iHeart Japan Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DSep 1, 2025
Series CJul 6, 2021
Series ANov 30, 2017
Series BMay 16, 2016

iHeart Japan Corporation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2025

    $6M round led by MS&AD Ventures and Mitsui Sumitomo Insurance

  • Jul 6, 2021

    $7.2M round from Miraidoa and NCB Venture Capital.

iHeart Japan Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iHeart Japan Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iHeart Japan Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersKyoto
Employee Range16
Year Founded2013
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?